Abstract | OBJECTIVES: METHODS: We extracted all the cases encoded 'polychondritis' from the computerized medical files of our department. The relapsing polychondritis diagnosis was confirmed using Damiani's criteria. Patients treated with biologics were evaluated for efficacy and adverse drugs reactions until October 2012. RESULTS: CONCLUSIONS:
|
Authors | Guillaume Moulis, Laurent Sailler, Grégory Pugnet, Leonardo Astudillo, Philippe Arlet |
Journal | Clinical and experimental rheumatology
(Clin Exp Rheumatol)
2013 Nov-Dec
Vol. 31
Issue 6
Pg. 937-9
ISSN: 0392-856X [Print] Italy |
PMID | 24021708
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Biological Products
- Tumor Necrosis Factor-alpha
|
Topics |
- Adult
- Anti-Inflammatory Agents
(adverse effects, therapeutic use)
- Biological Products
(adverse effects, therapeutic use)
- Drug Substitution
- Female
- Humans
- Male
- Middle Aged
- Polychondritis, Relapsing
(diagnosis, drug therapy, immunology)
- Retrospective Studies
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors, metabolism)
|